Annual Lung SPORE Workshop (Abstract Submission): Submission #67

serial: '67'
sid: '110626'
uuid: f2f38073-6cf0-4df5-9645-0a236130106c
uri: /dctd/lungsporemeeting/abstracts
created: '1710179994'
completed: '1710182868'
changed: '1715007595'
in_draft: '0'
current_page: ''
remote_addr: 10.208.28.228
uid: '0'
langcode: en
webform_id: lung_spore_investigator_abstract
entity_type: node
entity_id: '1171'
locked: '0'
sticky: '0'
notes: ''
data:
  additional_authors_list:
    - affiliation: DFCI
      first_name: Antja-Voy
      last_name: Hartley
    - affiliation: DFCI
      first_name: Simon
      last_name: Baldacci
    - affiliation: DFCI
      first_name: 'Matthew '
      last_name: Booker
    - affiliation: 'Stanford Cancer Institute'
      first_name: ' Nathanael '
      last_name: Gray
    - affiliation: DFCI
      first_name: Michael
      last_name: Tolsturokov
    - affiliation: DFCI
      first_name: Pasi
      last_name: Janne
  topic_classification:
    - 'Session 6: Cancer Biology'
  abstract_review_status: 'Approved to be a Poster Presenter'
  abstract_title: 'CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC)'
  affiliation_author1: DFCI
  affiliation_presenter: 'Dana-Farber Cancer Institute'
  email: mustafa_al-dulaimi@dfci.harvard.edu
  first_name: Mustafa
  first_name_author1: Mustafa
  last_name: Al-Dulaimi
  last_name_author1: Al-Dulaimi
  phone: '12087180181'
  poster_uploaded: ''
  special_characters_included_: '0'
  upload_abstract_1: '44496'
  upload_poster: ''